Evaluation of the role of UGT1A1 genotype testing in colorectal cancer patients administered irinotecan and the occurence of grade 3 and 4 neutropenia.

被引：2
|
作者：
Patel, Sushma M.
Chan, Jim
Hui, Rita L.
Spence, Michele M.
机构：
[1] Kaiser Permanente, Oakland, CA USA
[2] Kaiser Permanente, Downey, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.412
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
412
引用
收藏
页数：2
相关论文
共 50 条
  • [31] UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil
    Yan Wang
    Lin Shen
    Nong Xu
    Jin-Wan Wang
    Shun-Chang Jiao
    Ze-Yuan Liu
    Jian-Ming Xu
    World Journal of Gastroenterology, 2012, 18 (45) : 6635 - 6644
  • [32] UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil
    Wang, Yan
    Shen, Lin
    Xu, Nong
    Wang, Jin-Wan
    Jiao, Shun-Chang
    Liu, Ze-Yuan
    Xu, Jian-Ming
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (45) : 6635 - 6644
  • [33] Polymorphisms in UGT1A1 and UGT1A7 may predict irinotecan toxicity in patients with advanced colorectal cancer
    Lastraioli, S.
    Ponzanelli, A.
    Leonardi, F.
    Marroni, P.
    Serra, M.
    Sonaglio, C.
    Loiacono, F.
    Zuccaro, D.
    Naldi, N.
    Franzini, E.
    Boni, L.
    Paganuzzi, M.
    Ardizzoni, A.
    Chiara, S.
    Notaro, R.
    ANNALS OF ONCOLOGY, 2006, 17 : XI47 - XI47
  • [34] UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
    Masahide Onoue
    Tomohiro Terada
    Masahiko Kobayashi
    Toshiya Katsura
    Shigemi Matsumoto
    Kazuhiro Yanagihara
    Takafumi Nishimura
    Masashi Kanai
    Satoshi Teramukai
    Akira Shimizu
    Masanori Fukushima
    Ken-ichi Inui
    International Journal of Clinical Oncology, 2009, 14 : 136 - 142
  • [35] UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
    Onoue, Masahide
    Terada, Tomohiro
    Kobayashi, Masahiko
    Katsura, Toshiya
    Matsumoto, Shigemi
    Yanagihara, Kazuhiro
    Nishimura, Takafumi
    Kanai, Masashi
    Teramukai, Satoshi
    Shimizu, Akira
    Fukushima, Masanori
    Inui, Ken-ichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (02) : 136 - 142
  • [36] Impact of UGT1A1 genotype on prognosis in Japanese advanced colorectal cancer patients treated by irinotecan-based regimens.
    Ichikawa, Wataru
    Uehara, Keisuke
    Minamimura, Keisuke
    Tanaka, Chihiro
    Takii, Yasumasa
    Miyauchi, Hideaki
    Sadahiro, Sotaro
    Shinozaki, Katsunori
    Fukumoto, Kanehisa
    Otsuji, Toshio
    Kambara, Takeshi
    Morita, Satoshi
    Ando, Yuichi
    Okutani, Yukihiro
    Sugihara, Masahiro
    Sugiyama, Toru
    Ohashi, Yasuo
    Sakata, Yuh
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients
    Jada, Srinivasa Rao
    Lim, Robert
    Wong, Chiung Ing
    Shu, Xiaochen
    Lee, Soo Chin
    Zhou, Qingyu
    Goh, Boon Cher
    Chowbay, Balram
    CANCER SCIENCE, 2007, 98 (09): : 1461 - 1467
  • [38] UGT1A1*6/*28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients
    Jing Gao
    Jun Zhou
    Yanyan Li
    Ming Lu
    Ru Jia
    Lin Shen
    Medical Oncology, 2013, 30
  • [39] UGT1A1*6/*28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients
    Gao, Jing
    Zhou, Jun
    Li, Yanyan
    Lu, Ming
    Jia, Ru
    Shen, Lin
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [40] The UGT1A1*28 Genotype and the Toxicity of Low-Dose Irinotecan in Patients With Advanced Lung Cancer
    Sugiyama, Tomohide
    Hirose, Takashi
    Kusumoto, Sojiro
    Shirai, Takao
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Ohnishi, Tsukasa
    Ohmori, Tohru
    Adachi, Mitsuru
    ONCOLOGY RESEARCH, 2009, 18 (07) : 337 - 342
12345